Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.9 USD | 0.00% | 0.00% | +34.25% |
04-24 | Transphorm and Weltrend Semiconductor Release New Integrated Gan System-In-Packages | CI |
03-05 | Transphorm, Inc. Enter into Credit and Security Agreement with Renesas Electronics America Inc | CI |
Valuation
Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 261.4 | 377.2 | 227.5 | 310.5 | - |
Enterprise Value (EV) 1 | 261.4 | 377.2 | 227.5 | 310.5 | 310.5 |
P/E ratio | -40.6 x | -32.1 x | -7.39 x | -9.8 x | -16.3 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | 15.7 x | 13.8 x | 12.8 x | 7.61 x |
EV / Revenue | - | 15.7 x | 13.8 x | 12.8 x | 7.61 x |
EV / EBITDA | - | - | - | - | - |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | - | 10.4 x | 11.4 x | - | - |
Nbr of stocks (in thousands) | 40,279 | 53,355 | 57,017 | 63,358 | - |
Reference price 2 | 6.490 | 7.070 | 3.990 | 4.900 | 4.900 |
Announcement Date | 6/24/21 | 5/24/22 | 6/27/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Maart | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 11.37 | - | 24.05 | 16.51 | 24.17 | 40.8 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | -13.4 | - | -6.601 | -23.04 | -19.73 | -17.6 |
Operating Margin | -117.82% | - | -27.45% | -139.57% | -81.66% | -43.14% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income 1 | - | -6.579 | -10.24 | -30.6 | -32.2 | -18.5 |
Net margin | - | - | -42.56% | -185.32% | -133.24% | -45.34% |
EPS 2 | -0.5600 | -0.1600 | -0.2200 | -0.5400 | -0.5000 | -0.3000 |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/9/21 | 6/24/21 | 5/24/22 | 6/27/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 11.3 | 4.604 | 4.927 | 5.156 | 3.67 | 4.493 | 3.192 | 5.883 | 5.01 | 4.67 | 7.167 | 8.2 | 9.433 | 10.83 | 12.4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | 4.614 | -4.926 | -3.522 | -5.034 | -5.502 | -8.609 | -7.372 | -4.741 | -5.244 | -7.274 | -4.733 | -5.233 | -4.733 | -4.133 | -3.433 |
Operating Margin | 40.82% | -106.99% | -71.48% | -97.63% | -149.92% | -191.61% | -230.95% | -80.59% | -104.67% | -155.76% | -66.05% | -63.82% | -50.18% | -38.15% | -27.69% |
Earnings before Tax (EBT) | - | - | -4.999 | - | - | - | - | - | - | - | - | - | - | - | -2.3 |
Net income 1 | 5.98 | -4.164 | -4.999 | -5.353 | -5.995 | -10.46 | -8.79 | -7.447 | -7.129 | -12.72 | -6.4 | -6 | -5.4 | -4.8 | -2.3 |
Net margin | 52.91% | -90.44% | -101.46% | -103.82% | -163.35% | -232.81% | -275.38% | -126.59% | -142.3% | -272.42% | -89.3% | -73.17% | -57.24% | -44.31% | -18.55% |
EPS 2 | 0.1400 | -0.0800 | -0.0900 | -0.1000 | -0.1000 | -0.1800 | -0.1500 | -0.2200 | -0.1200 | -0.2000 | -0.1000 | -0.1000 | -0.1000 | -0.1000 | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/10/21 | 2/9/22 | 5/24/22 | 8/15/22 | 11/9/22 | 2/22/23 | 6/27/23 | 8/14/23 | 11/9/23 | 2/20/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | -0.6300 | - | 0.6800 | 0.3500 | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/9/21 | 6/24/21 | 5/24/22 | 6/27/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.25% | 310M | |
+84.48% | 2,248B | |
+39.12% | 661B | |
+23.63% | 640B | |
+30.66% | 211B | |
+12.13% | 174B | |
+46.25% | 138B | |
-38.21% | 132B | |
+55.23% | 121B | |
+6.74% | 105B |
- Stock Market
- Equities
- TGAN Stock
- Financials Transphorm, Inc.